AbbVie abandons late-stage lung cancer asset Rova-T - Physician's Weekly

AbbVie abandons late-stage lung cancer asset Rova-T  Physician's Weekly

Aug 29, 2019 | Reuters | 0 |. AbbVie abandons late-stage lung cancer asset Rova-T. (Reuters) – AbbVie Inc said on Thursday it will cease to develop its ...



Comments

Popular posts from this blog